lHeim_B

Tau4D phosphorylation.

AI Overview (Google's Gemini, March 26, 2026)

Yes, multiple phosphate (PO4) molecules can bind within the same functional regions or "pockets" of the tau protein, particularly in cases of hyperphosphorylation associated with Alzheimer’s disease.

Clustered Phosphorylation Sites: Tau is an intrinsically disordered protein (IDP) with about 85 potential phosphorylation sites. These sites are heavily clustered in the proline-rich region (residues 172-251) and the C-terminal tail (residues 368-441), which flank the microtubule-binding repeats. This high density means multiple phosphate groups often populate these regions simultaneously.
Binding Pocket Overlap: In the pathological, "hyperphosphorylated" state, the balance of kinases and phosphatases is disrupted, leading to the accumulation of many phosphate groups on a single tau molecule.
Specific Examples: Research shows that in Alzheimer’s diseased brains, hyperphosphorylated tau often has 5–9 phosphorylation sites modified, compared to only 2–3 in healthy adults.
Effect of Multiple Phosphates: The binding of multiple phosphates acts cumulatively. As more phosphate groups bind to tau, they remove the positive charge of the microtubule-binding region (MTBR), causing the tau protein to lose its affinity for microtubules, leading to aggregation.
Cooperative Binding: Phosphorylation at one site can sometimes prime or enhance phosphorylation at nearby sites within the same binding domain, facilitating the clustering of multiple phosphates.

In summary, the high concentration of potential sites in specific domains makes it likely that multiple phosphate groups reside in the same or closely positioned areas, directly causing the conformational changes that lead to pathology.

Order of binding	Receptor	Ligand	Affinity	Pocket ID	Residues that formed the binding pocket	Presence of SER, THR, TYR
1	Tau4D	PO4	-3.047	receptor_Tau4D_16	LYS-700 ALA-701 THR-703 ASP-704 HIS-705 ALA-707 ILE-709	THR-703
2	Tau4D	PO4	-2.954	receptor_Tau4D_10	ASP-270 PHE-271 SER-273 LYS-274	SER-273
3	Tau4D	PO4	-2.731	receptor_Tau4D_4	PRO-268 VAL-269 ASP-270 PHE-271 LEU-272 SER-273	SER-273
4	Tau4D	PO4	-2.772	receptor_Tau4D_4	PRO-268 VAL-269 ASP-270 PHE-271 LEU-272 SER-273	SER-273
5	Tau4D	PO4	-2.732	receptor_Tau4D_6	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
6	Tau4D	PO4	-2.602	receptor_Tau4D_6	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
7	Tau4D	PO4	-2.77	receptor_Tau4D_6	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
8	Tau4D	PO4	-2.629	receptor_Tau4D_6	VAL-604 GLN-605 SER-606 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
9	Tau4D	PO4	-2.5	receptor_Tau4D_16	LYS-700 ALA-701 THR-703 ASP-704 HIS-705 ALA-707 ILE-709	THR-703